Logo image of SPX.CA

STELLAR AFRICAGOLD INC (SPX.CA) Stock Fundamental Analysis

TSX-V:SPX - TSX Venture Exchange - CA85855B2012 - Common Stock - Currency: CAD

0.135  +0.02 (+12.5%)

Fundamental Rating

0

SPX gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 820 industry peers in the Metals & Mining industry. SPX may be in some trouble as it scores bad on both profitability and health. SPX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

SPX had negative earnings in the past year.
SPX had a negative operating cash flow in the past year.
SPX had negative earnings in 4 of the past 5 years.
SPX had a negative operating cash flow in each of the past 5 years.
SPX.CA Yearly Net Income VS EBIT VS OCF VS FCFSPX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M

1.2 Ratios

SPX has a worse Return On Assets (-188.10%) than 87.16% of its industry peers.
Industry RankSector Rank
ROA -188.1%
ROE N/A
ROIC N/A
ROA(3y)-252.97%
ROA(5y)-133.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPX.CA Yearly ROA, ROE, ROICSPX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPX.CA Yearly Profit, Operating, Gross MarginsSPX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

The number of shares outstanding for SPX has been increased compared to 1 year ago.
Compared to 5 years ago, SPX has less shares outstanding
SPX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SPX.CA Yearly Shares OutstandingSPX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SPX.CA Yearly Total Debt VS Total AssetsSPX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2.2 Solvency

SPX has an Altman-Z score of -80.17. This is a bad value and indicates that SPX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -80.17, SPX is doing worse than 89.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -80.17
ROIC/WACCN/A
WACCN/A
SPX.CA Yearly LT Debt VS Equity VS FCFSPX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M

2.3 Liquidity

A Current Ratio of 0.99 indicates that SPX may have some problems paying its short term obligations.
SPX's Current ratio of 0.99 is on the low side compared to the rest of the industry. SPX is outperformed by 63.51% of its industry peers.
SPX has a Quick Ratio of 0.99. This is a bad value and indicates that SPX is not financially healthy enough and could expect problems in meeting its short term obligations.
SPX has a Quick ratio of 0.99. This is in the lower half of the industry: SPX underperforms 60.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
SPX.CA Yearly Current Assets VS Current LiabilitesSPX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

0

3. Growth

3.1 Past

SPX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.33%.
EPS 1Y (TTM)-101.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPX.CA Yearly Revenue VS EstimatesSPX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
SPX.CA Yearly EPS VS EstimatesSPX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SPX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPX.CA Price Earnings VS Forward Price EarningsSPX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPX.CA Per share dataSPX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.01 -0.02 -0.03 -0.04 -0.05

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STELLAR AFRICAGOLD INC

TSX-V:SPX (2/21/2025, 7:00:00 PM)

0.135

+0.02 (+12.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners22.29%
Ins Owner ChangeN/A
Market Cap3.79M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -188.1%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-252.97%
ROA(5y)-133.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z -80.17
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.45%
OCF growth 3YN/A
OCF growth 5YN/A